You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

August 26, 2016

Product Labeling in Laos: New Regulations Require Local Language on Packaging

Informed Counsel

The Lao government has recently stepped up its efforts to raise public awareness of health issues and the quality of products sold in the market. The impetus behind the government’s actions is largely attributable to one main factor—in Laos, most products still do not have labeling in the Lao language to provide consumers with information about the product, despite this being a requirement. In the past, the government generally turned a blind eye to this shortcoming in consumer protection, but this is now set to change.

Regulatory Framework

The Department of Internal Trade, Ministry of Industry and Commerce, recently issued Announcement 1285,  restating the requirement to include labels in the Lao language on products. The Announcement also granted all business operators involved in the manufacturing, importing, wholesaling, distributing, and retailing of goods an extension, until August 29, 2016, to bring their labeling in line with the requisite regulations.

The Announcement follows Ordinance 2501/MoIC DDT concerning Product Labeling in the Lao Language, which the Ministry of Industry and Commerce introduced on December 16, 2015. The Ordinance entered into force this year on January 8, followed on March 11 by the Department of Internal Trade issuing Recommendation 0281/MoIC, which restated much of the Ordinance and provided additional information on how it should be implemented by affected business operators.

The main reason for the Announcement and the Recommendation, which restate the Ordinance, is that almost no changes were made in practice after the Ordinance entered into force. Unfortunately, the duties and responsibilities of the administration were not adequately clarified under the Ordinance, meaning that it could not be properly implemented. The private sector was also largely unaware of the Ordinance, and even those who were aware had generally not yet taken action to adhere to the product labeling requirements.

Purpose of the Ordinance

The Ordinance aims to help consumers gain a better understanding of the benefits and qualities of products before purchasing and using them. This helps consumers  avoid purchasing low-quality or expired products, which could adversely affect their health, property, or the environment. In addition, under the Ordinance, domestic manufacturers and importers are encouraged to label their products in the Lao language prior to distribution. And the Ordinance also attempts to clarify the duties and responsibilities of the administration.

The Ordinance, rephrasing the Law on Consumer Protection 02/NA of 2010, also sets out the duties and responsibilities of local administrators in administering and monitoring product labels in the Lao language, and it includes product labeling obligations for manufacturers, importers, and distributors. It implores them to use product labels in the Lao language, particularly for products that could potentially endanger the life, health, and safety of consumers.

Product Labeling Requirements

Under the Ordinance,  product labels must comply with Article 19 of the Law on Consumer Protection, which requires information on product labels regarding the type of goods; trademark registered by the manufacturer and the trademark used in trade by the importer in Laos; location of manufacture, the importer’s trading address in Laos, and the country of origin of the manufacturer, when this is not Laos; and price, amount, quality, weight and net weight, components and component percentage, directions for use, warnings, date of manufacture, and the expiration date.

The Recommendation of March 11 leaves open the possibility of adding more information requirements in the future. In line with Article 19 of the Law on Consumer Protection, descriptive product information must be accurate, and it must not exaggerate any benefits or qualities.

Penalties

The Law on Consumer Protection stipulates that any business operator supplying goods that are not labeled or that contain incorrect information will have their business license suspended. The Ordinance, however, specifies that business operators who are found guilty of infringement for the first time will not have their business license suspended immediately.

The Ordinance provides different levels of sanctions for different types of operators, with retailers being subject to more lenient treatment than manufacturers, importers, wholesalers, or distributors. First-time violators receive a notification of the violation and a warning. When a violation is found, business operators have one month to bring their product labeling in line with the requisite regulations. A failure to do so can result in fines of LAK 500,000 to LAK 1 million (USD 62 to USD 124) for retailers, and LAK 5 million to LAK 7 million (USD 620 to USD 871) for manufacturers, importers, wholesalers, or distributors.

If business operators continue to fail to adhere to the labeling requirements after the first and second violations described above, retailers are liable to a fine of LAK 1 million to LAK 2 million (USD 124 to USD 248) and they risk having their unlabeled goods seized. Manufacturers, importers, wholesalers, and distributors that are found guilty of the same offense are liable to even more severe penalties ranging from LAK 7 million to LAK 9 million (USD 871 to USD 1120) and the possibility of having their business license suspended for as long as the infringement continues.

Products Exempted from the Ordinance

The Ordinance does not apply to certain types of goods, and it also takes into account the final purpose of goods. Therefore, certain products in the Ordinance are exempted from labeling requirements, including goods temporarily imported for subsequent export, goods temporarily imported for exhibition before being exported back to the original country, and goods in transit; gifts and souvenirs; fresh food and condiments without packaging directly sold to consumers; and raw materials without packaging imported for manufacturing in an industrial factory or for construction.

For products that are imported before August 29, the number of products without a Lao language label to be sold in the Lao market needs to be reported to the administration, to allow them to be “distributable” in the country.

Despite these limited exemptions, the Ordinance and its related regulations provide for far-reaching requirements for all businesses in the consumer goods sector. Businesses should take action immediately to comply with the new requirements, while closely monitoring the practical enforcement by local authorities.

RELATED INSIGHTS​ 

July 13, 2026
Indonesia’s Halal Product Assurance Agency (BPJPH) has issued new regulations establishing clearer procedures for imposing administrative sanctions on businesses that violate halal product assurance requirements. BPJPH Regulation No. 2 of 2026 on the Imposition of Administrative Sanctions for Violations of Halal Product Assurance Implementation, issued on June 5, 2026, strengthens Indonesia’s halal compliance framework, as mandated under Law No. 33 of 2014 on Halal Product Assurance and Government Regulation No. 42 of 2024 on the Implementation of Halal Product Assurance. BPJPH Regulation No. 2/2026 also supports the upcoming mandatory halal compliance deadline of October 17, 2026, which will apply to a broad range of products and services, including imported food and beverages, slaughtering products and services, natural and quasi-drugs, health supplements, cosmetics, chemical and genetically engineered products, clothing and accessories, household goods, prayer equipment, stationery, and class A medical devices. Scope BPJPH is authorized to impose administrative sanctions for violations of halal product assurance requirements committed by businesses, halal inspection agencies (LPH), halal auditors, halal product process companion institutions (lembaga pendamping PPH), and halal product process companions (pendamping PPH). The head of BPJPH has authority to determine, cancel, or amend the imposition of administrative sanctions, including upon receipt of objections. This authority covers revocation of Halal Certificates (including foreign halal certificate registration numbers), withdrawal of goods from circulation, freezing of LPH operations, freezing of halal product process companion institutions, revocation of PPH companion institution registration numbers, revocation of halal auditor registration numbers, and revocation of LPH accreditation status. Administrative Sanctions Businesses may be subject to any of the following administrative sanctions: Written warning; Administrative fine; Revocation of the halal certificate, including revocation of foreign halal certificate registration numbers; and Withdrawal of goods from circulation. The regulation sets out the types of violations that may trigger these sanctions, with each
July 1, 2026
Obtaining marketing authorization is a fundamental requirement for bringing pharmaceutical products to the Thai market. Companies must navigate the Thai Food and Drug Administration’s registration procedures while also complying with post-approval pharmacovigilance obligations, licensing requirements for manufacturing and importation, data protection rules, and other regulatory requirements. This guide provides an overview of Thailand’s regulatory framework for pharmaceutical marketing authorization, including available registration pathways, review timelines, application fees, postmarketing surveillance obligations, licensing requirements, exemptions, data exclusivity, freedom of information, and parallel import considerations. It is intended as a practical reference for pharmaceutical companies, regulatory affairs professionals, and others involved in bringing medicinal products to the Thai market. Download the guide below for a concise overview of the current requirements and procedures governing pharmaceutical marketing authorization in Thailand.
June 24, 2026
Patent enablement requirements are provided under Article 102 of Vietnam’s Law on Intellectual Property (IP Law). In particular, a patent specification must “fully and clearly disclose the nature of the invention to such an extent that, based on the specification, a person having ordinary skill in the relevant art can implement the invention.” In pharmaceutical and biotechnology patents, this requirement is more complicated and subject to more rigorous assessment. The Patent Examination Guidelines (Guidelines) of the Intellectual Property Office of Vietnam (IP Office) were amended in March 2026 to introduce Annexes III and IV for the pharmaceutical and biotechnology sectors, in which Annex III provides detailed guidelines on the assessment of specification requirements. These amendments were made under a project for strengthening capacity in industrial property examination between the Japan International Cooperation Agency (JICA) and the IP Office. Annex III provides detailed instructions on how examiners assess enablement in a pharmaceutical or biotechnology application, and offers examples of acceptable and unacceptable descriptions with regard to the enablement aspect. Enablement Requirements in Pharma and Biotech Patents Article 12.7 of Circular 10/2026/TT-BKHCN (Circular 10) adds to the requirements of Article 102 of the IP Law that the description must demonstrate the novelty, inventive step, and industrial applicability of the technical solution. For pharmaceutical composition subject matters, Article 12.9 of Circular 10 sets out that the description must present the results of clinical trials and/or the pharmacological effects of the claimed pharmaceutical composition, and must include at least the following information: Substance/mixture used. Testing method (system) employed. Information on the test results. Correlation between the pharmacological effects obtained from the tests and the application of the pharmaceutical product in the prevention, diagnosis, and treatment of diseases. The Guidelines note that pharmacological study results should be presented in a quantified manner, and pharmacological
June 19, 2026
For the first time, Thailand’s Food and Drug Administration (FDA) has published a consolidated list identifying all substances that have successfully passed its novel food safety evaluation process. The list is a step forward in regulatory transparency, but it also highlights a feature of the Thai regime that food companies often overlook: each approval is tied exclusively to the company that applied for it. A substance’s appearance on the list does not give other companies the green light to use it. This article examines the structure of Thailand’s novel food approval framework, the implications of applicant exclusivity, and the strategic choices it requires of food companies looking to bring novel ingredients to the Thai market. Thai FDA Food Safety Evaluation Framework Notification No. 376 of the Ministry of Public Health requires novel food substances to undergo a food safety assessment, with an exemption only for novel foods manufactured exclusively for export. The framework also encompasses “foods that do not qualify as novel foods” but which present characteristics warranting a safety evaluation, such as differing quality standards, increased serving sizes, or applications in specific food categories, where such changes affect consumption levels, nutritional value, or consumer safety. The recently published list of foods that passed the safety evaluation by the Thai FDA is structured by substance category and identifies the approved company (domestic manufacturer or importer), country of origin, substance name and trade name, approved purpose of use, and date of the Thai FDA’s approval notification certificate. A notable feature of Thailand’s novel food regime is that the approval result is tied exclusively to the company that submitted the application. Publication of the consolidated list does not constitute a general authorization to use the approved substances. The Thai FDA’s approval certificate specifies the approved conditions of use and the requirements